Wuxi Apptec (Hongkong) LIMITED
Wuxi Apptec (Hongkong) LIMITED
- UEI
- JKRKL5UBGYY5
- CAGE
- SAQJ8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- wuxiapptec.com
- Founded
- 2000
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| NIH nhlbi lab researcher DR. Denis sviridov requires synthesis of triglycerides lowering peptides in order to… | National Heart Lung and Blood Institute | $3,300 | |
| The mission of the division of toxicology (DOT) in the office of applied research and safety assessment (oarsa),… | Food and Drug Administration | $24,263 | |
| Scale up of c-ABL lead NCGC00508975 250G | National Institute on Drug Abuse | $16,900 | |
| Synthesis of five to ten milligrams of seven analogues of aderbasib. | National Institute on Drug Abuse | $13,000 | |
| Laboratory testing | National Cancer Institute | $24,480 |
About Wuxi Apptec (Hongkong) LIMITED
Wuxi Apptec (Hongkong) LIMITED is a global company that provides a broad portfolio of R&D and manufacturing services to the pharmaceutical and healthcare industry, including chemistry drug CRDMO, biology discovery, preclinical testing, clinical research services, cell therapy, and gene therapy. Through prime federal contract awards, Wuxi Apptec (Hongkong) LIMITED has provided chemical compounds, small molecule compound libraries, analogues, and other materials to the National Institutes of Health (NIH), including the National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI), National Institute on Drug Abuse, National Heart Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases. The contract awards have been for purposes such as testing anti-cancer drug candidates, lowering triglycerides, DNA conjugation chemistry, and scaling up lead compounds. None of the prime contract awards have had any set aside designations. Wuxi Apptec (Hongkong) LIMITED has also received one sub contract award from Selux Diagnostics to provide critical material for a G2 Inoculator.
Quick answers
What is Wuxi Apptec (Hongkong) LIMITED's UEI?
Wuxi Apptec (Hongkong) LIMITED's Unique Entity ID (UEI) in SAM.gov is JKRKL5UBGYY5.
What is Wuxi Apptec (Hongkong) LIMITED's CAGE code?
Wuxi Apptec (Hongkong) LIMITED's CAGE code is SAQJ8.
What is Wuxi Apptec (Hongkong) LIMITED's primary NAICS code?
Wuxi Apptec (Hongkong) LIMITED's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Is Wuxi Apptec (Hongkong) LIMITED registered in SAM.gov?
Wuxi Apptec (Hongkong) LIMITED's SAM.gov registration expired on November 12, 2022.
What is Wuxi Apptec (Hongkong) LIMITED's most recent federal award?
Wuxi Apptec (Hongkong) LIMITED's most recent federal contract award is NIH nhlbi lab researcher DR. Denis sviridov requires synthesis of triglycerides lowering peptides in order to… (75N92022P00066), from National Heart Lung and Blood Institute, on January 18, 2022.
On GovTribe
See Wuxi Apptec (Hongkong) LIMITED's full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors